1. Home
  2. MI vs ALZN Comparison

MI vs ALZN Comparison

Compare MI & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NFT Limited

MI

NFT Limited

HOLD

Current Price

$15.86

Market Cap

3.3M

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.19

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MI
ALZN
Founded
2009
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MI
ALZN
Price
$15.86
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
76.5K
44.6K
Earning Date
05-07-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.84
52 Week High
$19.84
$4.30

Technical Indicators

Market Signals
Indicator
MI
ALZN
Relative Strength Index (RSI) 71.72 53.46
Support Level $2.44 $1.03
Resistance Level $19.84 $1.25
Average True Range (ATR) 1.32 0.08
MACD 0.86 0.02
Stochastic Oscillator 78.69 56.90

Price Performance

Historical Comparison
MI
ALZN

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: